Cash Flows (Tables)

3 Months Ended

Mar. 31, 2023

Cash and Cash Equivalents [Abstract]

Schedule of Cash and Cash Equivalents

The following provides a reconciliation of cash, cash equivalents, and restricted cash reported within the Condensed Consolidated Balance Sheet to the total of the same such amounts shown in the Condensed Consolidated Statement of Cash Flows:

	March 31,
(In millions)	2023		2022
Cash and cash equivalents	$	3,916.3	$	3,345.7
Restricted cash included in Other noncurrent assets	12.5		13.5
Total cash, cash equivalents, and restricted cash shown in the Condensed Consolidated Statement of Cash Flows	$	3,928.8	$	3,359.2

Restrictions on Cash and Cash Equivalents

The following provides a reconciliation of cash, cash equivalents, and restricted cash reported within the Condensed Consolidated Balance Sheet to the total of the same such amounts shown in the Condensed Consolidated Statement of Cash Flows:

	March 31,
(In millions)	2023		2022
Cash and cash equivalents	$	3,916.3	$	3,345.7
Restricted cash included in Other noncurrent assets	12.5		13.5
Total cash, cash equivalents, and restricted cash shown in the Condensed Consolidated Statement of Cash Flows	$	3,928.8	$	3,359.2

Summary of Non-Cash Investing and Financing Activities

	March 31,		December 31,		March 31,		December 31,
(In millions)	2023		2022		2022		2021
Accrued capital expenditures	$	90.3	$	70.8	$	80.7	$	74.8
Accrued contingent consideration for Libtayo intangible asset	$	55.2	$	135.5	$	—	$	—